Insulin Action (Scheme 1). These pathways are triggered by hormones such as insulin and adrenaline but also by nutritional factors such as amino acids and glucose. In addition, intracellular conditions such as the glycogen content of the cells can significantly influence the degree of stimulation of these pathways. Clearly, further knowledge of the interaction between the different inputs will be necessary to gain a full understanding of the control of glycogen synthesis under various metabolic conditions. Work in our laboratory was supported by Diabetes UK, BBSRC, Novo Nordisk, Glaxo SmithKline and Xcellsyz. 
ation of eukaryotic initiation factors and elongation factors (eIFs and eEFs respectively) and of other regulatory proteins. This modulates their activities or their abilities to interact with one another. Insulin activates several of these proteins including the following : the guanine-nucleotide exchange factor eIF2B ; the eIF4F complex, which (through eIF4E) interacts with the cap of the mRNA; p70 S6 kinase; and elongation factor eEF2, which mediates the translocation step of elongation. Control of the last three of these is linked to mTOR (mammalian target of rapamycin). In Chinese hamster ovary cells, regulation of all these proteins by insulin is modulated by the presence of amino acids and/or glucose in the medium. For example, p70 S6 kinase activity declines in the absence of amino acids and cannot be stimulated by insulin under this condition. T h e readdition of amino acids, especially leucine, restores activity and sensitivity to insulin. With eIF2B and eEF2, both amino acids and glucose must be provided for insulin to regulate their activities. In contrast, insulin-stimulation of the formation of eIF4F complexes requires glucose but not amino acids. Glucose metabolism is required for this permissive effect. Our recent studies have also identified the mechanism by which mTOR signalling regulates the phosphorylation of eEF2. eEF2 kinase is phosphorylated by p70 S6 kinase at Ser-366; this results in the inactivation of eEF2 kinase, especially at low (micromolar) Ca concentrations.
Introduction
T h e control of mRNA translation in mammalian cells involves changes in the states of phosphorylation and function of multiple components of the translational machinery. These components include initiation and elongation factors (eIFs and eEFs respectively) and ribosomal proteins. Protein synthesis is activated by hormones such as insulin and by growth factors and is inhibited under stressful conditions. Its stimulation by insulin has been the subject of considerable investigation and several steps in the process of mRNA translation are now known to be regulated by this hormone [l] . More recently it has become clear that the ability of insulin to modulate the activities and/or states of phosphorylation of these proteins is affected by the nutrient status of the cell, for example the availability of glucose or amino acids [2] . Here we summarize the current understanding of the impact of nutrient conditions on the control of translation, focusing on the interplay between nutrients and the regulation of these proteins by insulin, an area in which this group has been active. A excellent short review of this subject was published recently [2] .
Several regulatory components of the translational machinery are controlled through the rapamycin-sensitive mTOR (mammalian target of rapamycin) signalling pathway. mTOR is a large multidomain protein of 290 kDa including a region that shows similarity to lipid kinases of the phosphoinositide kinase family [3] . Rapamycin [when bound to FKBP-12 (FK506-binding protein)] inhibits the activity of mTOR, so the sensitivity of a given event to rapamycin indicates a role for mTOR. Three regulatory steps in mRNA translation are known to depend on mTOR. First, the activation of the 70 kDa protein kinase that phosphorylates ribosomal protein S6 (p70 S6 kinase) is blocked by rapamycin. S6 phosphorylation is believed to be important in upregulation (e.g. by insulin or serum) of the translation of the set of mRNA species termed 5'-TOP (tract of pyrimidine) mRNA species, which encode ribosomal proteins and elongation factors. Up-regulation of their translation, which is also blocked by rapamycin, thus offers a mechanism by which the synthesis of these components of the translational machinery can be quickly increased in response to agents that turn on protein synthesis Secondly, the phosphorylation of the e I F 4E-binding proteins 1 and 2 (4E-BPI and 2) is also blocked by rapamycin (reviewed in [6, 7] ). By interacting with eIF4E, these proteins block its ability to interact with the scaffolding protein eIF4G and form eIF4F complexes competent to bind 40 S subunits and participate in scanning to locate the start codon on the mRNA. eIF4E has a key role here because it binds to the 5' cap (7-methylguanosine) of the mRNA and thus recruits eIF4F to the 5' end of the mRNA. 4E-BPI undergoes phosphorylation in response, for example, to insulin at multiple sites [6, 7] . Evidence has been provided that at least some of these sites are direct substrates for mTOR ' s protein kinase activity [8, 9] .
Thirdly, the phosphorylation of eEF2 is under the control of signalling via mTOR [ 10,111. Phosphorylation of eEF2 (at Thr-56) inhibits its activity. Insulin induces the dephosphorylation of this site and this involves a decreased activity of eEF2 kinase [ 1 &12], a Ca'+/calmodulin-dependent enzyme that does not belong to the main protein kinase superfamily [13] . Both the inactivation of eEF2 kinase and the dephosphorylation of eEF2 are blocked by rapamycin [10, 14] , demonstrating that these effects require mTOR.
Insulin also activates the guanine-nucleotide exchange factor eIF2B, which is important in the overall control of translation initiation. This seems to involve a decreased phosphorylation of eIF2B's catalytic ( E ) subunit at an inhibitory phosphorylation site that is a target for glycogen synthase kinase 3 (GSK3) [15] . Insulin inactivates GSK3 via signalling through phosphoinositide 3-kinase and protein kinase B (PKB); activation of eIF2B Normal medium -insulin +insulin
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Results and discussion

Amino acids and glucose modulate the regulation of elF2B
Insulin activates eIF2B within 15 min in Chinese hamster ovary (CHO) cells [ 16, 171 . When CHO cells were transferred to medium lacking amino acids or glucose [Dulbecco's phosphate-buffered saline (D-PBS)], insulin no longer activated eIF2B. This was not due to a defect in the ability of insulin to activate PKB, inactivate GSK3 or induce the dephosphorylation of the GSK3 site in eIF2Bc [17] (Table 1) . This implies that other regulatory events are involved here to allow insulin to activate eIF2B. T o explore whether glucose or amino acids were the key regulator, C H O cells were transferred to D-PBS containing either 5 m M D-glucose, amino acids (mixture) or both. Only in the presence of both amino acids and glucose was insulin able to induce the activation of eIF2B. It therefore seems that glucose plus amino acids generates an input required for the activation of eIF2B independently of the GSK3 phosphorylation site in eIF2Bc. Thus additional inputs must be involved.
Regulation of 4E-BP I and p70 S6 kinase by insulin
When C H O cells are shifted into medium lacking amino acids, 4E-BPI rapidly undergoes dephosphorylation, as manifested by its altered mobility on SDS/PAGE: the dephosphorylated form(s) run faster than the more phosphorylated ones [18] . As expected, this net dephosphorylation of 4E-BP1 results in its increased binding to eIF4E and loss of eIF4F complexes [less eIF4G was associated with eIF4E in amino-acid-starved cells (Figure lA) ].
This suggested that amino acids themselves exert an effect, directly or indirectly, on the signalling events that modulate the phosphorylation of 4E-BPI. Consistent with this, readdition of a mixture of amino acids led to increased phosphorylation of 4E-BP1, its dissociation from eIF4E and increased levels of eIF4F complexes ( Figure 1A) . T h e formation of eIF4F complexes was not increased further by insulin, showing that amino acids themselves suffice to drive the formation of these complexes in C H O cells. No single amino acid alone was able to elicit this effect at the concentration found in the mixture, although high concentrations of leucine did bring about a partial phosphorylation of 4E-BPI [18] . This permissive effect of leucine has also been reported by others (reviewed in [2]). It is important to note that the administration of leucine increases protein synthesis and eIF4F in muscle in vivo [19] and that amino acids can themselves promote muscle protein synthesis in the absence of insulin [20] .
Because the phosphorylation of 4E-BP1 depends on mTOR, it was possible that the effects of amino acids on 4E-BPI phosphorylation were mediated through modulation of the mTOR pathway. T o study this, we examined the effects of amino acid withdrawal on the phosphorylation of another target of mTOR signalling, p70 S6 kinase. Withdrawal of amino acids caused the inactivation of p70 S6 kinase [17] . These studies also revealed that amino acids are required for the regulation of p70 S6 kinase by insulin: in control These results show that amino acids exert a dual effect on the control of p70 S6 kinase: maintaining its basal activity and also acting to permit its activation by insulin. Analogous results were also reported by others [21-231. For 4E-BP1 the situation is different, as described above. Amino acids alone seem to suffice for the full formation of eIF4F complexes in these cells but not for the full activation of p70 S6 kinase, which also requires an additional input, for example insulin.
Glucose also modulates the responsiveness of 4E-BP I phosphorylation to insulin
Glucose also alters the regulation of 4E-BP1 by insulin. In cells deprived of glucose and amino acids, insulin is unable to induce any detectable change in the mobility of 4E-BP1. T h e use of phosphospecific antisera revealed that under this condition, insulin could bring about the phosphorylation of Thr-69 but not Thr-36/45 or Ser-64 (J. V. Patel, X. Wang and C. G . Proud, unpublished work). In contrast, for cells in medium containing D-glucose (5 mM), insulin brought about a substantial shift of 4E-BPI into the most highly phosphorylated y form. Analysis with the use of the phosphospecific antisera revealed that this was associated with increased phosphorylation of Thr-36/45 and Ser-64. Thus D-glucose exerts a permissive effect with regard to insulin-induced phosphorylation of 4E-BPI. Glucose analogues that can be transported but not fully metabolized did not support insulin-induced phosphorylation of 4E-BPI (J. V. Patel, X. Wang and C. G. Proud, unpublished work). However, two other hexoses, D-mannOSe and D-glucosamine, did exert a similar permissive effect to that of insulin. Thus it seems that hexose metabolism is necessary for this effect, which is not specific for glucose. One possibility is that a metabolite of glucose provides this 'signal '; it is not clear at this point whether this acts allosterically to modulate a component of the signalling pathways regulating mTOR and/or 4E-BP1 phosphorylation. This picture differs from the situation for p70 S6 kinase, in which glucose alone did not act permissively with respect to the activation of p70 S6 kinase by insulin [ 171.
Phosphorylation of eEF2 is also modulated by nutrients T h e ability of insulin to bring about the dephosphorylation of eEF2 is blocked by rapamycin [lo] . In experiments similar to those described above for eIF2B and 4E-BP1, both glucose and a mixture of amino acids were required as components of the medium for insulin to bring about significant dephosphorylation of eEF2 [17] . This strongly supports the emerging picture that amino acids regulate mTOR-coupled signalling pathways in mammalian cells.
Recent work in this laboratory has revealed new insights into the regulation of eEF2. First, these studies have delineated a mechanism by which insulin, through mTOR, brings about the Scheme I inactivation of eEF2 kinase (eEF2k) and the dephosphorylation of eEF2. eEF2k is efficiently phosphorylated by p70 S6 kinase 1 (and a newly discovered isoform, S6 kinase 2). This occurs at a single, conserved serine residue (Ser-366 of human eEF2k) and results in the inactivation of eEF2k especially at low (1-5 pM) Ca2+ concentrations. Mutation of Ser-366 to Ala prevents phosphorylation, whereas mutation to Glu results in an enzyme with a low basal activity at low [Ca"], indicating that it mimics the effect of phosphorylation. This identifies eEF2k as a new substrate for p70 S6 kinase and explains how insulin activates peptide chain elongation (Scheme 1 ).
Recent work in this laboratory has shown that treatment of CHO cells with 5-amino-4-imidazolecarboxamide riboside (AICAriboside) causes a substantial increase in the level of phosphorylation of eEF2. After entry into the cell, AICAriboside is converted to an analogue of 5'-AMP key roles in nutrient regulation in yeast and plants, phosphorylates and regulates several enzymes and other proteins to switch off energy-consuming processes and activate energy-generating ones [24] . Thus, when A T P levels are low (and AMP is high), for example after glucose deprivation, the cell can cut down on energy expenditure and turn on A T P production. Because protein synthesis is the second most energy-consuming process in the cell, it would be important to decrease the rate of mRNA translation to save A T P for the most essential processes. Our results suggest that activation of AMP-k leads to inhibition of peptidechain elongation, which would have exactly this desirable effect. Preliminary results show that AMP-k phosphorylates eEF2k at two or more sites; studies are under way to identify them and to study their roles in regulating eEF2k activity. I t is possible that the permissive effect of glucose on the ability of insulin to bring about the dephosphorylation of eEF2 is connected to the regulation 
Role of mTOR in the regulation of translation
The regulation of several proteins that control mRNA translation is linked to rnTOR: 4E-BP I controls the formation of elF4F complexes, whereas the phosphorylation of 56 is thought t o regulate the translation of the 5'-TOP (tract of pyrimidine) mRNA species in a positive manner. As shown in Scheme I, the control of eEF2 is also mediated via mTOR and this affects global protein synthesis rather than the translation of specific mRNA species. Signalling t o all three proteins is affected by amino acid supply, and for eEF2 and 4E-BPI, glucose acts permissively with regard t o their control by insulin. The activity of elF2B is regulated through a different pathway involving the phosphorylation and inactivation of GSK3 by PKB, leading t o the dephosphorylation and activation of elF2B. The activation of elF2B is also modulated by glucose and amino acids but this seems t o require (as yet unknown) inputs distinct from the PKB/GSK3 pathway. 
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'sense' that its activation should be dependent on both amino acids and a source of metabolic energy. However, the signalling/regulatory events involved in these processes remain obscure. T h e control of mTOR and its downstream signalling components are very poorly understood, and much future work will focus on these issues. Different regulatory inputs must be involved in the control of eIF2B, because its activation is not blocked by rapamycin [ 161.
It is also not known how cells 'sense' nutrient levels. T h e requirement for metabolizable glucose analogues tends to suggest that gluose metabolism rather than a glucose receptor (such as yeast Rgt2 or Snf3 [25] ) is involved. Yeast also possesses an amino acid sensor [26] and it is conceivable that such a system also operates in mammalian cells, especially given the rapidity of the response to amino acid withdrawal or addition (on the scale of a few minutes). However, some results suggest that amino acid metabolism might be involved; the picture is very far from clear [2,27]. Delineation of the sensing and signalling events involved in nutrient regulation in mammals is not only of fundamental importance for our understanding of mammalian cell physiology but also of substantial clinical significance in relation, for example, to human (ma1)nutrition and other conditions.
Introduction
Glucose homeostasis is a major requirement for survival in mammals because this substrate is used continuously at a high rate by organs such as the
